Register entry

Argenta US Manufacturing LLC

Data as of · How to read this entry

Registered sites
4
Active NDC listings
0
Live patents
0
Countries
3
Base
United States
Authorisation

Registered operations

Analytical testing4Active ingredient (API) manufacture1Labelling4Finished drug manufacture4Packaging4Relabelling3Repackaging3
Sites

Registered establishments

4
EstablishmentAddressRegistered forFEI / DUNS
Argenta Dundee LimitedRegistrant: Argenta LimitedKinnoull Road Dunsinane Industrial Estate, Dundee, DD2 3XR, United Kingdom (GBR)Analytical testing, Labelling, Finished drug manufacture, Packaging, Relabelling, Repackaging3002792064222283763
Argenta Limited2 Sterling Avenue Manurewa, Auckland, 2102, New Zealand (NZL)Analytical testing, Labelling, Finished drug manufacture, Packaging, Relabelling, Repackaging3005379357593772127
AML Riverside, LlcRegistrant: Argenta Limited141 Riverside Dr, Fort Dodge, Iowa (IA) 50501, United States (USA)Analytical testing, Labelling, Finished drug manufacture, Packaging, Relabelling, Repackaging1931411089899815
Argenta US Manufacturing LLC12707 Shawnee Mission Pkwy, Shawnee, Kansas (KS) 66216, United States (USA)Analytical testing, Active ingredient (API) manufacture, Labelling, Finished drug manufacture, Packaging0001910953119402875
Neighbours

Registered in the same town

1
Compare

Comparable companies in United States

Enquiry

Common questions

Is Argenta US Manufacturing LLC FDA approved?
Argenta US Manufacturing LLC holds 4 FDA-registered establishments across 3 countries. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
Where are Argenta US Manufacturing LLC's drugs manufactured?
At registered sites in the United Kingdom, New Zealand, the United States. The FDA register lists Dundee; Auckland; Fort Dodge, IA; Shawnee, KS. Registered operations: analytical testing, active ingredient (API) manufacture, labelling, finished drug manufacture, packaging, relabelling, repackaging.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.